Vident Advisory’s Fresenius Medical Care FMS Stock Holding History

Vident Advisory’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$920K	Sell	40,709 -4,391	-10%	-$98.6K	0.01%	1013
2026 Q1	$1.02M	Buy	45,100 +2,884	+7%	+$66.3K	0.01%	869
2025 Q4	$1.01M	Sell	42,216 -1,716	-4%	-$42.7K	0.01%	810
2025 Q3	$1.16M	Buy	43,932 +9,577	+28%	+$246K	0.01%	760
2025 Q2	$982K	Sell	34,355 -19,919	-37%	-$535K	0.01%	746
2025 Q1	$1.35M	Buy	54,274 +30,864	+132%	+$735K	0.02%	608
2024 Q4	$530K	Buy	23,410 +2,464	+12%	+$53.5K	0.01%	912
2024 Q3	$446K	Buy	20,946 +2,682	+15%	+$52.8K	0.01%	989
2024 Q2	$349K	Buy	+18,264	New	+$372K	0.01%	1064

Other funds holding FMS

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

Vident Advisory's FMS Position: Q2 2026 in Review

Vident Advisory reduced its Fresenius Medical Care (FMS) stake by 9.7% in Q2 2026, selling an estimated $98.6K and leaving 40,709 shares worth $920K. The position accounts for 0.01% of the portfolio, ranked #1013.

Vident Advisory first reported a position in FMS in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.35M in Q1 2025. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

Vident Advisory held 40,709 shares of Fresenius Medical Care worth $920K as of Q2 2026.
Vident Advisory sold 4,391 Fresenius Medical Care shares in Q2 2026, an estimated $98.6K.
Fresenius Medical Care made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #1013 holding.
Vident Advisory first reported a position in Fresenius Medical Care in Q2 2024 and has held it in 9 quarters since.
Vident Advisory's Fresenius Medical Care position peaked at $1.35M in Q1 2025.
234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.